Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 18.82
0.00 (0.00%)
At close: Dec 23, 2025
Celon Pharma Market Cap
Celon Pharma has a market cap or net worth of 1.01 billion as of December 26, 2025. Its market cap has decreased by -28.03% in one year.
Market Cap
1.01B
Enterprise Value
1.01B
Revenue
225.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.82
Market Cap Chart
Since December 1, 2016, Celon Pharma's market cap has increased from 1.00B to 1.01B, an increase of 1.10%. That is a compound annual growth rate of 0.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 1.01B | -28.85% |
| Dec 30, 2024 | 1.42B | 80.47% |
| Dec 29, 2023 | 789.33M | 10.32% |
| Dec 30, 2022 | 715.51M | -57.68% |
| Dec 30, 2021 | 1.69B | -7.35% |
| Dec 30, 2020 | 1.82B | 2.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.70B |
| NEUCA | 3.65B |
| Synektik Spólka Akcyjna | 2.35B |
| Voxel | 1.27B |
| Selvita | 750.74M |
| Ryvu Therapeutics | 586.10M |
| Centrum Medyczne ENEL-MED | 509.05M |
| Scope Fluidics | 454.33M |